- Home
- VYNE vs SCOR Comparison
VYNE vs SCOR Comparison
Compare VYNE & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- SCOR
- Stock Information
- Founded
- VYNE 2003
- SCOR 1999
- Country
- VYNE United States
- SCOR United States
- Employees
- VYNE N/A
- SCOR N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- SCOR Business Services
- Sector
- VYNE Health Care
- SCOR Consumer Discretionary
- Exchange
- VYNE Nasdaq
- SCOR Nasdaq
- Market Cap
- VYNE 41.9M
- SCOR 34.7M
- IPO Year
- VYNE 2018
- SCOR 2007
- Fundamental
- Price
- VYNE $2.32
- SCOR $7.38
- Analyst Decision
- VYNE Strong Buy
- SCOR Buy
- Analyst Count
- VYNE 2
- SCOR 3
- Target Price
- VYNE $6.88
- SCOR $12.83
- AVG Volume (30 Days)
- VYNE 129.4K
- SCOR 37.0K
- Earning Date
- VYNE 02-27-2025
- SCOR 03-05-2025
- Dividend Yield
- VYNE N/A
- SCOR N/A
- EPS Growth
- VYNE N/A
- SCOR N/A
- EPS
- VYNE N/A
- SCOR N/A
- Revenue
- VYNE $493,000.00
- SCOR $356,212,000.00
- Revenue This Year
- VYNE $28.30
- SCOR N/A
- Revenue Next Year
- VYNE N/A
- SCOR $2.92
- P/E Ratio
- VYNE N/A
- SCOR N/A
- Revenue Growth
- VYNE 39.27
- SCOR N/A
- 52 Week Low
- VYNE $1.57
- SCOR $4.89
- 52 Week High
- VYNE $4.30
- SCOR $20.42
- Technical
- Relative Strength Index (RSI)
- VYNE 36.13
- SCOR 55.55
- Support Level
- VYNE $2.34
- SCOR $6.79
- Resistance Level
- VYNE $3.00
- SCOR $7.49
- Average True Range (ATR)
- VYNE 0.27
- SCOR 0.57
- MACD
- VYNE -0.08
- SCOR 0.11
- Stochastic Oscillator
- VYNE 8.24
- SCOR 58.58
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.